Cytokinetics (CYTK)
(Real Time Quote from BATS)
$56.36 USD
-0.32 (-0.57%)
Updated Oct 7, 2024 02:22 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/7/24 |
---|---|
Current Quarter | -1.26 |
EPS Last Quarter | -1.31 |
Last EPS Surprise | -28.43% |
ABR | 1.56 |
Earnings ESP
|
-2.67% |
---|---|
Current Year | -5.15 |
Next Year | -4.91 |
EPS (TTM) | -5.37 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.73M | 12.99M | 12.15M | 59.68M |
# of Estimates | 7 | 8 | 10 | 9 |
High Estimate | 20.00M | 52.00M | 54.00M | 225.90M |
Low Estimate | 0.75M | 0.75M | 1.08M | 14.25M |
Year ago Sales | 0.38M | 1.67M | 7.53M | 12.15M |
Year over Year Growth Est. | 882.11% | 677.96% | 61.37% | 391.16% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.26 | -1.27 | -5.15 | -4.91 |
# of Estimates | 11 | 10 | 12 | 10 |
Most Recent Consensus | -1.30 | -1.60 | -5.50 | -6.70 |
High Estimate | -1.08 | -0.75 | -4.59 | -3.50 |
Low Estimate | -1.46 | -1.60 | -5.60 | -6.70 |
Year ago EPS | -1.35 | -1.38 | -5.45 | -5.15 |
Year over Year Growth Est. | 6.67% | 7.97% | 5.50% | 4.80% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 1 | 1 |
Down Last 60 Days | 9 | 8 | 11 | 8 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.26 | -1.27 | -5.15 | -4.91 |
7 Days Ago | -1.26 | -1.27 | -5.15 | -4.91 |
30 Days Ago | -1.25 | -1.26 | -5.10 | -4.84 |
60 Days Ago | -1.09 | -1.11 | -4.50 | -4.28 |
90 Days Ago | -1.09 | -1.11 | -4.50 | -4.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.29 | -1.41 | -5.42 | -5.79 |
Zacks Consensus Estimate | -1.26 | -1.27 | -5.15 | -4.91 |
Earnings ESP | -2.67% | -11.37% | -5.18% | -18.02% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.31 | -1.33 | -1.38 | -1.35 | NA |
Estimate | -1.02 | -1.16 | -1.03 | -0.72 | NA |
Difference | -0.29 | -0.17 | -0.35 | -0.63 | -0.36 |
Surprise | -28.43% | -14.66% | -33.98% | -87.50% | -41.14% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more